We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBF icon
5076
ProShares Short 20+ Year Treasury ETF
TBF
$106M
$164K ﹤0.01%
7,000
EWM icon
5077
iShares MSCI Malaysia ETF
EWM
$331M
$163K ﹤0.01%
5,051
MBIN icon
5078
Merchants Bancorp
MBIN
$2.5B
$163K ﹤0.01%
9,563
+7,535
+372% +$135K
OSG
5079
DELISTED
Overseas Shipholding Group Inc.
OSG
$163K ﹤0.01%
51,942
-8,253
-14% -$28.8K
CBRL icon
5080
CALL
Cracker Barrel
CBRL
$1.25B
$162K ﹤0.01%
1,100
-20,700
-95% -$3.1M
CNI icon
5081
CALL
Canadian National Railway
CNI
$76.4B
$162K ﹤0.01%
1,800
-1,900
-51% -$166K
COLL icon
5082
Collegium Pharmaceutical
COLL
$843M
$162K ﹤0.01%
11,019
+4,709
+75% +$83.5K
BLUE
5083
CALL
DELISTED
bluebird bio
BLUE
$161K ﹤0.01%
85
-6,029
-99% -$12.5M
SVRA icon
5084
Savara
SVRA
$1.14B
$161K ﹤0.01%
14,435
+12,592
+683% +$145K
NXEO
5085
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$161K ﹤0.01%
13,106
-1,798
-12% -$18K
BCOV
5086
DELISTED
Brightcove, Inc.
BCOV
$160K ﹤0.01%
19,088
+6,662
+54% +$57.2K
HIBB
5087
CALL
DELISTED
Hibbett, Inc. Common Stock
HIBB
$160K ﹤0.01%
8,500
+4,600
+118% +$104K
FMS icon
5088
Fresenius Medical Care
FMS
$12.7B
$159K ﹤0.01%
3,104
-23,096
-88% -$1.16M
KNX icon
5089
PUT
Knight Transportation
KNX
$11.2B
$159K ﹤0.01%
4,604
-3,800
-45% -$133K
HCCI
5090
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$159K ﹤0.01%
7,409
-1,728
-19% -$37.8K
CBPO
5091
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$159K ﹤0.01%
2,002
-145
-7% -$13.5K
BCRX icon
5092
PUT
BioCryst Pharmaceuticals
BCRX
$2.64B
$158K ﹤0.01%
20,700
+14,200
+218% +$95.4K
BY icon
5093
Byline Bancorp
BY
$1.76B
$158K ﹤0.01%
6,943
+5,749
+481% +$132K
GDDY icon
5094
PUT
GoDaddy
GDDY
$11.5B
$158K ﹤0.01%
1,900
-600
-24% -$46.8K
JKS
5095
CALL
JinkoSolar
JKS
$873M
$158K ﹤0.01%
14,700
-20,100
-58% -$267K
FMNB icon
5096
Farmers National Banc Corp
FMNB
$952M
$157K ﹤0.01%
10,270
+8,214
+400% +$131K
FRO icon
5097
CALL
Frontline
FRO
$8.49B
$157K ﹤0.01%
27,100
+1,000
+4% +$5.28K
HELE icon
5098
PUT
Helen of Troy
HELE
$682M
$157K ﹤0.01%
1,200
-5,300
-82% -$624K
ONCT
5099
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$157K ﹤0.01%
+714
New +$1.71M
IIN
5100
DELISTED
IntriCon Corporation
IIN
$157K ﹤0.01%
2,784
+2,199
+376% +$129K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.